Dermata Therapeutics- Warrants (13/08/2026) Overview
Dermata Therapeutics- Warrants (13/08/2026) Discounted Cash Flow
DCF Analysis for DRMAW.
Get informed when a big investor buys or sells
+ FollowFair Value
$2.07
Current Fair Value
$2.07
↑ 15918.6% Upside
Undervalued by 15918.6% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison